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I read the recent paper by Zumhagen and colleagues with great interest, who 
demonstrated that the interval from the peak to the end of the electrocardiographic T wave 
(Tpeak – Tend) and (Tpeak – Tend)/QT ratio, were strongly risk markers for Brugada patients with 
life-threatening ventricular arrhythmias 
1
. These ratios reflect the transmural dispersion of 




Nevertheless, Tpeak – Tend, (Tpeak – Tend)/QT ratio and TDR do not take into account 
the contribution of cellular depolarization or action potential conduction, which is abnormal 
in Brugada syndrome 
3
. The latter finding is in keeping with prolonged QRS duration on the 
electrocardiogram that suggests intra-ventricular conduction delay 
4
. Pre-clinical experiments 
suggest that excitation wavelength, λ, given by conduction velocity x effective refractory 
period), may be a better predictor of arrhythmogenicity, because it combines both 
depolarization and repolarization parameters. However, a major disadvantage of λ is that it 
must be determined invasively. A recent study proposed calculating the ratio of the time 
taken of repolarization to that of depolarization, i.e. QT/QRS (index of Cardiac 
Electrophysiological Balance, iCEB) 
5
. The advantage of this index is that it can be easily 
determined from the electrocardiogram and can be used by the bedside to approximate λ.  
Given that Tpeak-Tend interval is a better predictor of arrhythmic risk than QT interval, 
it follows that it should replace QT interval in the calculation of iCEB. Thus, I propose two 
novel markers, (Tpeak-Tend)/QRS and Tpeak-Tend / (QT x QRS) for stratification of arrhythmic 
risk. (Tpeak-Tend)/QRS can easily be calculated by the bedside or in the clinic, whereas (Tpeak-
Tend)/(QT x QRS) is potentially more accurate for use in epidemiological studies. Both 
indices are firmly based on physiological principles that λ is critical in the determination of 
arrhythmic tendency. Their validity will require further investigation, and may ultimately 
provide better predictive values than Tpeak-Tend or (Tpeak – Tend)/QT ratio. 
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